Hey Eisai good luck selling Lenvima against the Yervoy and Opdivo indication in RCC that has a PDUFA date this month.. if your sales weren’t small enough already. Don’t miss selling these dog products. PS MC sucks so does KO
One step further in the grave? Yea ok, I guess that's why those "dopes" at Merck approached Eisai for a collaboration/joint development agreement and shelled out a ton of money. http://investors.merck.com/news/press-release-details/2018/Eisai-Co-Ltd-and-Merck-Enter-Global-Strategic-Oncology-Collaboration-for-LENVIMA-lenvatinib-mesylate/default.aspx From the article "Per the agreement, the companies will also jointly initiate new clinical studies evaluating the LENVIMA/KEYTRUDA combination to support 11 potential indications in six types of cancer (endometrial cancer, non-small cell lung cancer, hepatocellular carcinoma, head and neck cancer, bladder cancer and melanoma), as well as a basket trial targeting multiple cancer types."
Why don’t you look at Lenvimas current market share in RCC and DTC.. i scale arched my head on how Merck was fooled unless they have good data that is still unpublished in lung. The drugs a dog. I sold it.
Merck was fooled? They're the one who approached Eisai. I'm sure they did their due diligence before hand. As far as Lenvima being a dog and you sold it, perhaps you were the dog not the drug.
